| 000 | 01509 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514163528.0 | ||
| 264 | 0 | _c20040720 | |
| 008 | 200407s 0 0 eng d | ||
| 022 | _a0049-8254 | ||
| 024 | 7 |
_a10.1080/00498250310001609156 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSandholm, A | |
| 245 | 0 | 0 |
_aBioavailability and half-life of decabromodiphenyl ether (BDE-209) in rat. _h[electronic resource] |
| 260 |
_bXenobiotica; the fate of foreign compounds in biological systems _cNov 2003 |
||
| 300 |
_a1149-58 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 | _aBiotransformation |
| 650 | 0 | 4 |
_aBromobenzenes _xpharmacokinetics |
| 650 | 0 | 4 |
_aFlame Retardants _xpharmacokinetics |
| 650 | 0 | 4 | _aGas Chromatography-Mass Spectrometry |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aHalogenated Diphenyl Ethers |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPhenyl Ethers |
| 650 | 0 | 4 | _aPolybrominated Biphenyls |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aSolvents |
| 650 | 0 | 4 | _aTissue Distribution |
| 700 | 1 | _aEmanuelsson, B-M | |
| 700 | 1 | _aWehler, E Klasson | |
| 773 | 0 |
_tXenobiotica; the fate of foreign compounds in biological systems _gvol. 33 _gno. 11 _gp. 1149-58 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/00498250310001609156 _zAvailable from publisher's website |
| 999 |
_c14393925 _d14393925 |
||